Jingmin Zhao

968 total citations
30 papers, 760 citations indexed

About

Jingmin Zhao is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingmin Zhao has authored 30 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 13 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingmin Zhao's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (9 papers). Jingmin Zhao is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (9 papers). Jingmin Zhao collaborates with scholars based in China, New Zealand and United States. Jingmin Zhao's co-authors include Xiaodong Guo, Fengmin Lu, Lu Xiong, Lin Zou, Mingjie Yao, Mei Yang, Ting Sun, Hanwei Li, Shaojun Xing and Dongping Xu and has published in prestigious journals such as PLoS ONE, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jingmin Zhao

27 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingmin Zhao China 17 284 278 251 184 172 30 760
Neru Munshi United States 9 151 0.5× 258 0.9× 275 1.1× 247 1.3× 65 0.4× 13 741
Indu Kohaar United States 14 219 0.8× 98 0.4× 236 0.9× 109 0.6× 171 1.0× 34 655
Marcy Clayton United States 9 200 0.7× 113 0.4× 197 0.8× 61 0.3× 74 0.4× 11 434
Yanan Gao China 9 77 0.3× 80 0.3× 199 0.8× 165 0.9× 100 0.6× 11 505
Hong Bu China 11 122 0.4× 221 0.8× 253 1.0× 157 0.9× 105 0.6× 39 729
Chohee Yun United States 13 369 1.3× 395 1.4× 180 0.7× 91 0.5× 53 0.3× 27 760
Kenichi Taguchi Japan 16 134 0.5× 197 0.7× 235 0.9× 214 1.2× 105 0.6× 19 688
Laura Santangelo Italy 14 168 0.6× 203 0.7× 954 3.8× 144 0.8× 609 3.5× 16 1.3k
Zuzanna Makowska Switzerland 13 277 1.0× 297 1.1× 570 2.3× 106 0.6× 414 2.4× 21 1.1k

Countries citing papers authored by Jingmin Zhao

Since Specialization
Citations

This map shows the geographic impact of Jingmin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmin Zhao more than expected).

Fields of papers citing papers by Jingmin Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingmin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmin Zhao. The network helps show where Jingmin Zhao may publish in the future.

Co-authorship network of co-authors of Jingmin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingmin Zhao. A scholar is included among the top collaborators of Jingmin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingmin Zhao. Jingmin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Jingmin, et al.. (2023). Carotid free-floating thrombus revealed by optical coherence tomography. Journal of Vascular Surgery. 80(4). 1292–1293. 1 indexed citations
2.
Yao, Mingjie, Hong You, Jianwen Wang, et al.. (2019). Serum GP73 combined AST and GGT reflects moderate to severe liver inflammation in chronic hepatitis B. Clinica Chimica Acta. 493. 92–97. 20 indexed citations
3.
Wen, Xiajie, Mingjie Yao, Yiwei Lu, et al.. (2018). Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery. Journal of Clinical and Translational Hepatology. 6(xx). 1–8. 20 indexed citations
4.
Jiang, Lina, Mei Yang, Xi Li, et al.. (2018). CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte–Stellate Cell Crosstalk. The Journal of Clinical Endocrinology & Metabolism. 103(11). 3974–3985. 17 indexed citations
5.
Liu, Tianhui, Mingjie Yao, Shuhong Liu, et al.. (2017). Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma. Oncotarget. 8(10). 16498–16506. 32 indexed citations
6.
Xie, Xiaomeng, Mingjie Yao, Xiajie Wen, et al.. (2016). [Correlation between red blood cell count and liver function status].. PubMed. 24(2). 119–22. 4 indexed citations
7.
Shen, Honghui, Bingke Bai, Yaqing Wang, et al.. (2015). Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B. Experimental and Therapeutic Medicine. 9(3). 999–1005. 5 indexed citations
8.
Zhao, Jingmin, Zhengsheng Zou, Yan Liu, et al.. (2014). Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection. PLoS ONE. 9(2). e89046–e89046. 31 indexed citations
9.
Zhong, Yanwei, Xu Chen, Dongping Xu, et al.. (2014). A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR. BMC Infectious Diseases. 14(1). 608–608. 19 indexed citations
10.
Guo, Xiaodong, et al.. (2013). Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma. Cancer Epidemiology. 37(5). 732–736. 36 indexed citations
11.
Guo, Xiaodong, Lu Xiong, Ting Sun, et al.. (2012). Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma. Diagnostic Pathology. 7(1). 44–44. 87 indexed citations
12.
Fu, Junliang, Zheng Zhang, Lin Zhou, et al.. (2012). Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Hepatology. 58(1). 139–149. 159 indexed citations
13.
Guo, Xiaodong, et al.. (2012). Upregulation of Bone Morphogenetic Protein 4 is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma. Pathology & Oncology Research. 18(3). 635–640. 41 indexed citations
14.
Zang, Hong, Jingmin Zhao, Dong Ji, et al.. (2012). [Expression of CAS in hepatocellular carcinoma tissues and its relationship with HBV infection].. PubMed. 26(4). 285–7. 1 indexed citations
15.
Guo, Xiaodong, Lu Xiong, Lin Zou, et al.. (2012). L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Diagnostic Pathology. 7(1). 96–96. 22 indexed citations
16.
Zhong, Yanwei, Jiaqi Han, Zhengsheng Zou, et al.. (2011). Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clinica Chimica Acta. 412(21-22). 1905–1911. 33 indexed citations
17.
Xu, Zhihui, Yan Liu, Teng Xu, et al.. (2010). Acute hepatitis B infection associated with drug-resistant hepatitis B virus. Journal of Clinical Virology. 48(4). 270–274. 41 indexed citations
18.
Li, Yajuan, Qing Xie, Fengmin Lu, et al.. (2009). Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver International. 30(1). 112–118. 31 indexed citations
19.
Zhou, Guangde, Jingmin Zhao, Xiaohui Ding, et al.. (2007). Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system. Frontiers of Medicine in China. 1(4). 413–417. 1 indexed citations
20.
Zhao, Jingmin, Guangde Zhou, Yanling Sun, et al.. (2003). [Clinical pathology and pathogenesis of severe acute respiratory syndrome].. PubMed. 17(3). 217–21. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026